The U.S. Food and Drug Administration (FDA) has granted traditional approval to Selpercatinib for the treatment of locally advanced or metastatic RET fusion-positive solid tumors.

老虎证券2026/07/14 18:27

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This drug was developed by Eli Lilly, and its approval this time marks a further expansion of its application scope, providing a new treatment option for cancer patients with specific genetic mutations.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Selpercatinib for the treatment of locally advanced or metastatic RET fusion-positive solid tumors.

You may also like

Crypto prices